Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors

This study has been completed.
Georgetown University
Information provided by:
INSYS Therapeutics Inc Identifier:
First received: September 24, 2001
Last updated: April 12, 2011
Last verified: April 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: October 2004
  Estimated Primary Completion Date: No date given